The UK Reality: Barriers to Effective Treatment UK patients face severe restrictions and limited options: NICE guidance (2022): Liposuction can only be done as part of a research study due to safety concerns NHS barriers: Limited specialist services, extensive waiting lists, and geographic inequality Conservative treatments: While compression therapy and lymphatic drainage can help manage symptoms, they dont address the underlying condition or reduce the abnormal fat deposits Treatment gap: Despite evidence for surgical effectiveness, UK patients have virtually no NHS access to interventional procedures Many resort to private treatment, medical tourism, or ongoing suffering while awaiting policy changes
Always put consistency first and talk openly with your healthcare provider for the best results on your health journey
As with any medical treatment, however, it is important to understand how your body may respond before beginning the journey
Each peptide carries default vial sizes, dose ranges, and notes on the correct diluent to reduce injection site reactions
BPC-157: VEGF Upregulation, GH Receptor Sensitisation, and Collagen Remodelling BPC-157, formally Body Protection Compound 157, is a synthetic 15-amino acid peptadecapeptide derived from a gastroprotective protein in human gastric juice